10.0 Drug List Flashcards
Vesamicol
Non-competative and reversible blocker of VAChT
Varenicline
High affinity partial agonist for the α4β2nAChRs<div>High affinity full agonst for the α7nAChRs</div>
Trimetaphan
Competative antagonist of the (α3)2(β2)3isoform of the nAChR
Hexamethonium
Competative antagonist of the (α3)2(β2)3isoform of the nAChR
Tetramethylammonium (TMA)
Neuronal (Nn) nAChR agonist
Dimethylphenylpiperazinium (DMPP)
Neuronal (Nn) nAChR agonist
Suxamethonium
Depolarising nAChR antagonist that initially activates the receptor but isnt hydrolysed by AChE so causes a secondary antagonism
Curare (d-tubocurarine)
Non-depolarising nAChR antagonist
Pancuronium
Synthetic non-depolarising aminosteriod nAChR antagonist
Rocuronium
Synthetic non-depolarising aminosteriod nAChR antagonist
Atracurium
Synthetic non-depolarising nAChR antagonist (benzylisoquinolinium)
Mivacurium
Synthetic non-depolarising nAChR antagonist (benzylisoquinolinium)
Botulinum toxin (BTx)
Peptidase that cleaves SNARE proteins to prevent release of ACh, hence blocking cholinergic neurotransmission
α-bungarotoxin
Irreversibly binds to the ACh binding site on the adult nAChR hence blocking cholinergic neurotransmission
β-bungarotoxin
Inhibits ACh release through a mechanism thought to involve phospholipase A2, which leads to blockage of cholinergic neurotransmission
α-lacrotoxin
Causes massive release and subsequent depletion of ACh at the NMJ thought to be due to its ability to form a Ca2+channel
Tetanus neurotoxin
Cleaves synaptobrevin to prevent glycine release by inhibitory interneurones upsteam of those innervating skeletal muscle
Bethanechol
Choline ester that acts as a non-selective agonist of mAChRs
Pilocarpine
mAChR agonist that is stable to hydrolysis by AChE
Atropine
Non-selective mAChR antagonist
Scopoloamine
Non-selective mAChR antagonist
Homatropine
Non-selective mAChR antagonist
Methscopolamine
Non-selective mAChR antagonist
Ipratropium
Short-acting non-selective mAChR antagonist (SAMA) with some selectivity for M3receptors in the airways
Tiotropium
Long-acting non-selective mAChR antagonist (LAMA) with some selectivity for M3receptors in the airways
Glycopyrronium
Long-acting non-selective mAChR antagonist (LAMA) with some selectivity for M3receptors in the airways
Tropicamide
Non-selective mAChR antagonist
Cyclopentolate
Non-selective mAChR antagonist
Pirenzepine
M1selective mAChR antagonist
Darifenacin
M3selective mAChR antagonist
Solifenacin
M3selective mAChR antagonist
Endrophonium
Non-covalent, reversible, short-acting AChE inhibitor
Neostigmine
Covalent, reversible, medium-acting AChE inhibitor
Physostigmine
Covalent, reversible, medium-acting AChE inhibitor
Ecothiophate
Long-acting, irreversible AChE inhibitor
Nerve gases (tabun, sarin, novichok etc.)
Long-acting, irreversible AChE inhibitors
Isoprenaline
β-selective AR agonist
Noradrenaline
αAR-selective agonist
Adrenaline
Non-selective AR agonist
α-Methyldopa
Competative inhibitor of tyrosine hydroxylase
L-DOPA
Product of tyrosine hydroxylase that can boos dopamine synthesis
Carbidopa
Inhibitor of peripheral DOPA decarboxylase
Disulfiram
Inhibitor of dopamine β hydroxylase
α-Μethyldopa
False transmitter released with DA and NA that acts as an α2-selective AR agonist
Reserpine
Irreversible blocker of VMAT2-mediated monoamine uptake into vesicles
Guanethidine
Low doses block impulse conduction at adrenergic synapses<div>High doses leads to a depletion of NA</div>
Dexamfetamine
Indirectly-acting sympatheticomimetic that causes adrenergic neurotransmitter release via a Ca2+-independant mechansim
Ephedrine
Mixed acting sympatheticomimetic that causes both release of NA and acts directly as an agonist at adrenoceptors
Imipramine
TCA that inhibits NET/Uptake 1
6-Hydropamine
Synthetic neurotoxin used to destroy dopaminergic neurones and induce PD in animal models
Phenoxybenzamine
Irreversible αAR antagonist that also blocks ENT/Uptake 2 at high concentrations
Normetanephrine
Metabolite of NA that blocks ENT/Uptake 2
Entacapone
COMT inhibitor
Xylometazoline
αAR-selective agonist
Phenylephrine
α1AR-selective agonist
Clonidine
α2AR-selective agonist
Dobutamine
β1AR-selective agonist
Salbutamol
Short-acting β2AR-selective agonist
Terbutaline
Short-acting β2AR-selective agonist
Salmeterol
Long-acting β2AR-selective agonist
Formerol
Long-acting β2AR-selective agonist
Indacaterol
Long-acting β2AR-selective agonist
Mirabegron
β3AR-selective agonist
Phentolamine
αAR-selective antagonist
Phenoxybenzamine
αAR-selective antagonist
Prazosin
α1AR-selective and competative antagonist
Idazoxan
α2AR-selective antagonist
Tamsulosin
α1AAR-selective antagonist
Yohimbine
α2AR-selective antagonist
Propranolol
Non-selective βAR antagonist
Atenolol
β1AR-selective antagonist
Bisoprolol
β1AR-selective antagonist
Carvedilol
Mixed α1/βAR-selective antagonist that exhibits G-protein signalling bias
Nebivolol
3rd generation β1AR-selective antagonist that also stimulates NO(g) release
Caffeine
Competative antagonist of the A1 adenosine receptors
Regadenoson
A2A-selective adenosine receptor agonist
Tetracaine
Use-dependant neuronal-selective Na+channel blocker
Benzocaine
Use-dependant neuronal-selective Na+channel blocker
RAC-421
Synthetic neuronal-selective Na+channel blocker
QX-314
Synthetic use-dependant Na+channel blocker
Nifedapine
Dihydropyridine smooth muscle-selective Ca2+channel blocker